Search results
Results from the WOW.Com Content Network
LATE is a prevalent condition in late life and can contribute to memory loss and cognitive decline, according to report co-author Rebecca M. Edelmayer, Ph.D., Alzheimer’s Association vice ...
Alzheimer’s-related memory loss is more than just not being able to remember someone’s name. “[We’re talking about] forgetting major events or having a loss of whole episodes,” Dr ...
Memory lapses like these are common for people of all ages. “Mild forgetfulness — you forget somebody’s name or where you left something — that’s totally normal,” says Karlene Ball, Ph.D.
As the disease advances, symptoms can include problems with language, disorientation (including easily getting lost), mood swings, loss of motivation, self-neglect, and behavioral issues. [2] As a person's condition declines, they often withdraw from family and society. [16] Gradually, bodily functions are lost, ultimately leading to death.
Lacunar amnesia is the loss of memory about a specific event. This specific form of amnesia is caused by brain damage in the limbic system which is responsible for our memories and emotions. When the damage occurs it leaves a lacuna, or a gap, in the record of memory within the cortex region of the brain. There is a general belief that certain ...
In the subtype known as color anomia, the patient can distinguish between colors but cannot identify them by name or name the color of an object. [5] The patients can separate colors into categories, but they cannot name them. Semantic anomia is caused by damage to the angular gyrus. This is a disorder in which the meaning of words becomes lost.
Wandering and getting lost. Losing things or misplacing them in odd places. Mood and personality changes. Increased anxiety and/or aggression. Moderate Alzheimer's disease: Increased memory loss ...
The treatment will depend on the cause of memory loss, but various drugs to treat Alzheimer's disease have been suggested in recent years. There are four drugs currently approved by the Food and Drug Administration (FDA) for the treatment of Alzheimer's, and they all act on the cholinergic system: Donepezil, Galantamine, Rivastigmine, and ...